RedHill Biopharma Ltd (RDHL): RedHill Biopharma Announces Proposed Pub...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	144
Posts	27610
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Friday, 12/02/2022 12:38:19 AM

Friday, December 02, 2022 12:38:19 AM

RedHill Biopharma Announces Proposed Public Offering

https://finance.yahoo.com/news/redhill-biopharma-announces-proposed-public-210100467.html

TEL AVIV, Israel and RALEIGH, N.C., Dec. 1, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it intends to offer and sell, subject to market and other conditions American Depositary Shares ("ADSs") (or pre-funded warrants in lieu thereof) and warrants to purchase ADSs (the "Warrants") in an underwritten public offering. Each ADS represents 10 of our ordinary shares, par value NIS 0.01 per share. The Company expects to grant the underwriter a 30-day option to purchase additional ADSs and/or Warrants at the public offering price, less the underwriting discounts and commissions. All of the securities to be sold in the offering are to be offered by RedHill.